Literature DB >> 18707898

Roles of ubiquitination in pattern-recognition receptors and type I interferon receptor signaling.

Annie Bibeau-Poirier1, Marc J Servant.   

Abstract

Post-translational protein modifications are involved in all functions of living cells. This includes the ability of cells to recognize pathogens and regulate genes involved in their clearance, a concept known as innate immunity. While phosphorylation mechanisms play essential roles in regulating different aspects of the innate immune response, ubiquitination is now recognized as another post-translational modification that works in parallel with phosphorylation to orchestrate the final proper innate immune response against invading pathogens. More precisely, this review will discuss the most recent advances that address the role of ubiquitination in pattern-recognition receptors and type I interferon receptor signaling.

Mesh:

Substances:

Year:  2008        PMID: 18707898     DOI: 10.1016/j.cyto.2008.07.012

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  30 in total

1.  A Structural View of Negative Regulation of the Toll-like Receptor-Mediated Inflammatory Pathway.

Authors:  Emine Guven-Maiorov; Ozlem Keskin; Attila Gursoy; Ruth Nussinov
Journal:  Biophys J       Date:  2015-08-11       Impact factor: 4.033

Review 2.  Ubiquitination-mediated regulation of interferon responses.

Authors:  Serge Y Fuchs
Journal:  Growth Factors       Date:  2012-03-07       Impact factor: 2.511

3.  Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases.

Authors:  Mark A Clementz; Zhongbin Chen; Bridget S Banach; Yanhua Wang; Li Sun; Kiira Ratia; Yahira M Baez-Santos; Jie Wang; Jun Takayama; Arun K Ghosh; Kui Li; Andrew D Mesecar; Susan C Baker
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

4.  Ataxia telangiectasia mutated kinase mediates NF-κB serine 276 phosphorylation and interferon expression via the IRF7-RIG-I amplification loop in paramyxovirus infection.

Authors:  Ling Fang; Sanjeev Choudhary; Bing Tian; Istvan Boldogh; Chunying Yang; Teodora Ivanciuc; Yinghong Ma; Roberto P Garofalo; Allan R Brasier
Journal:  J Virol       Date:  2014-12-17       Impact factor: 5.103

Review 5.  Immunomodulatory cytokines as therapeutic agents for melanoma.

Authors:  Courtney Nicholas; Gregory B Lesinski
Journal:  Immunotherapy       Date:  2011-05       Impact factor: 4.196

6.  Ubiquitin-regulated recruitment of IkappaB kinase epsilon to the MAVS interferon signaling adapter.

Authors:  Suzanne Paz; Myriam Vilasco; Meztli Arguello; Qiang Sun; Judith Lacoste; Thi Lien-Anh Nguyen; Tiejun Zhao; Elena A Shestakova; Scott Zaari; Annie Bibeau-Poirier; Marc J Servant; Rongtuan Lin; Eliane F Meurs; John Hiscott
Journal:  Mol Cell Biol       Date:  2009-04-20       Impact factor: 4.272

7.  The papain-like protease of porcine epidemic diarrhea virus negatively regulates type I interferon pathway by acting as a viral deubiquitinase.

Authors:  Yaling Xing; Jianfei Chen; Jian Tu; Bailing Zhang; Xiaojuan Chen; Hongyan Shi; Susan C Baker; Li Feng; Zhongbin Chen
Journal:  J Gen Virol       Date:  2013-04-17       Impact factor: 3.891

8.  CDK9-dependent transcriptional elongation in the innate interferon-stimulated gene response to respiratory syncytial virus infection in airway epithelial cells.

Authors:  Bing Tian; Yingxin Zhao; Mridul Kalita; Chukwudi B Edeh; Slobodan Paessler; Antonella Casola; Michael N Teng; Roberto P Garofalo; Allan R Brasier
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

9.  A functionally relevant IRF5 haplotype is associated with reduced risk to Wegener's granulomatosis.

Authors:  Stefan Wieczorek; Julia U Holle; Stephanie Müller; Harald Fricke; Wolfgang L Gross; Jörg T Epplen
Journal:  J Mol Med (Berl)       Date:  2010-01-05       Impact factor: 4.599

Review 10.  Antiviral activity of innate immune protein ISG15.

Authors:  Ronald N Harty; Paula M Pitha; Atsushi Okumura
Journal:  J Innate Immun       Date:  2009       Impact factor: 7.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.